A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.

作者: AG Chalmers , J Hunter , CD Lees , JA Millar , JJ Brown

DOI: 10.1111/J.1365-2125.1979.TB04778.X

关键词:

摘要: 1 The effects of labetalol, bethanidine and combined treatment with both drugs were compared in a within-patient randomized cross-over study mild essential hypertension. Attention was directed to whether or not labetalol differed their pattern effect on arterial BP evidence synergism apparent. 2 At the doses used significantly lowered systolic diastolic BPs heart rate lying, sitting, standing after exercise. dose did affect while lowering only exercise less clearly standing. Combined 3 type frequency side-effects similar but much treatment. 4 No observed.

参考文章(9)
R. A. Maxwell, W. B. Wastila, Adrenergic Neuron Blocking Drugs Springer Berlin Heidelberg. pp. 161- 261 ,(1977) , 10.1007/978-3-642-66309-3_5
Robertson Ji, Rosei Ea, Robertson As, Lever Af, Brown Jj, Trust Pm, Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. British Journal of Clinical Pharmacology. ,vol. 3, pp. 809- ,(1976)
W D Alexander, Letter: Guanethidine in hypertension. BMJ. ,vol. 1, pp. 1341- 1341 ,(1976) , 10.1136/BMJ.1.6021.1341-A
Dean T. Mason, Eugene Braunwald, Effects of Guanethidine, Reserpine, and Methyldopa on Reflex Venous and Arterial Constriction in Man* Journal of Clinical Investigation. ,vol. 43, pp. 1449- 1463 ,(1964) , 10.1172/JCI105021
R.N. Brogden, R.C. Heel, T.M. Speight, G.S. Avery, Labetalol Drugs. ,vol. 15, pp. 251- 270 ,(1978) , 10.2165/00003495-197815040-00002
G. SANDLER, A. W. D. LEISHMAN, P. M. HUMBERSTONE, Guanethidine-Resistant Hypertension Circulation. ,vol. 38, pp. 542- 551 ,(1968) , 10.1161/01.CIR.38.3.542
Dollery Ct, Closing remarks: current status of labetalol. British Journal of Clinical Pharmacology. ,vol. 3, pp. 823- 824 ,(1976)